Praxis Precision Medicines Announces Inducement Grants
Praxis Precision Medicines announced that on October 1, 2026, its Compensation Committee granted inducement awards under Nasdaq Listing Rule 5635(c)(4).
Praxis Precision Medicines announced that on October 1, 2026, its Compensation Committee granted inducement awards under Nasdaq Listing Rule 5635(c)(4).